Wong JB - Search Results

1

Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms.

Gordon CE, Uhlig K, Lau J, Schmid CH, Levey AS, Wong JB. Gordon CE, et al. Among authors: wong jb. Am J Kidney Dis. 2008 Feb;51(2):263-77. doi: 10.1053/j.ajkd.2007.11.003. Am J Kidney Dis. 2008. PMID: 18215704 Review.

2

Screening for acquired cystic kidney disease: a decision analytic perspective.

Sarasin FP, Wong JB, Levey AS, Meyer KB. Sarasin FP, et al. Among authors: wong jb. Kidney Int. 1995 Jul;48(1):207-19. doi: 10.1038/ki.1995.286. Kidney Int. 1995. PMID: 7564081 Free article.

3

Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B.

Wong JB, Koff RS, Tinè F, Pauker SG. Wong JB, et al. Ann Intern Med. 1995 May 1;122(9):664-75. doi: 10.7326/0003-4819-122-9-199505010-00004. Ann Intern Med. 1995. PMID: 7702228

4

Modeling therapeutic benefit in the midst of uncertainty: therapy for hepatitis C.

Bennett WG, Pauker SG, Davis GL, Wong JB. Bennett WG, et al. Among authors: wong jb. Dig Dis Sci. 1996 Dec;41(12 Suppl):56S-62S. doi: 10.1007/BF02087877. Dig Dis Sci. 1996. PMID: 9011477

5

Interferon treatment for chronic hepatitis B or C infection: costs and effectiveness.

Wong JB. Wong JB. Acta Gastroenterol Belg. 1998 Apr-Jun;61(2):238-42. Acta Gastroenterol Belg. 1998. PMID: 9658620

6

Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs.

Wong JB, Bennett WG, Koff RS, Pauker SG. Wong JB, et al. JAMA. 1998 Dec 23-30;280(24):2088-93. doi: 10.1001/jama.280.24.2088. JAMA. 1998. PMID: 9875876

7

Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk.

Engels EA, Ellis CA, Supran SE, Schmid CH, Barza M, Schenkein DP, Koc Y, Miller KB, Wong JB. Engels EA, et al. Among authors: wong jb. Clin Infect Dis. 1999 Feb;28(2):256-66. doi: 10.1086/515103. Clin Infect Dis. 1999. PMID: 10064241

8

Cost-effectiveness of treatments for chronic hepatitis C.

Wong JB. Wong JB. Am J Med. 1999 Dec 27;107(6B):74S-78S. doi: 10.1016/s0002-9343(99)00388-5. Am J Med. 1999. PMID: 10653463

9

Cytomegalovirus immune globulin after liver transplantation: a cost-effectiveness analysis.

Arbo MD, Snydman DR, Wong JB, Goldberg HS, Schmid CH, Pauker SG. Arbo MD, et al. Among authors: wong jb. Clin Transplant. 2000 Feb;14(1):19-27. doi: 10.1034/j.1399-0012.2000.140105.x. Clin Transplant. 2000. PMID: 10693631 Clinical Trial.

10

Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C.

Wong JB, Davis GL, Pauker SG. Wong JB, et al. Am J Med. 2000 Apr 1;108(5):366-73. doi: 10.1016/s0002-9343(00)00303-x. Am J Med. 2000. PMID: 10759092 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters